FDA Warns Two Companies About Bogus Opioid Addiction Treatment
Tianeptine-containing dietary supplements can pose a number of health risks
FDA Approves Drug for Treatment of Travelers’ Diarrhea
Aemcolo not indicated for patients with diarrhea complicated by fever and/or bloody stool
FDA Approves Drug to Treat Rare Immune Disease
Gamifant first drug to be approved specifically for primary hemophagocytic lymphohistiocytosis
Immunotherapy Side Effects May Be More Common Than Thought
Higher rates of adverse events observed for immune checkpoint inhibitors in real-world settings
Dementia Tied to Mortality in Older Adults With Down Syndrome
Crude mortality rates for individuals with dementia were five times higher than for those without
USPSTF Suggests Universal HIV Screening, PrEP for High-Risk Patients
Screening recommended for those ages 15 to 65 years, including pregnant women
American College of Allergy, Asthma & Immunology, Nov. 15-19
The 2018 Annual Meeting of the American College of Allergy, Asthma & Immunology The annual meeting of the American College of Allergy, Asthma...
Pain Management Telementoring May Cut Opioid Prescribing
Declines seen in annual prescriptions per patient, dose per patient, and number of opioid users
Onset of Musculoskeletal Adverse Events Varies Between Statins
Significantly faster onset with atorvastatin, rosuvastatin versus simvastatin during monotherapy
HIV Transmission Risk Small With Antiretroviral Compliance
No transmissions with antiretroviral tx, viral load of less than 200 copies/mL four to six months apart
